Introduction
Dr. Yu Xianjun (虞先濬) is the Director of the Department of Pancreatic Surgery at Fudan University Shanghai Cancer Center (FUSCC), and one of China's foremost experts in pancreatic cancer surgery and oncology. With over 20 years of specialized experience and one of the highest-volume pancreatic surgery practices in Asia, Dr. Yu is internationally recognized as a pioneer in minimally invasive and radical pancreatic surgery. His groundbreaking work in pancreatic cancer treatment has improved survival outcomes for thousands of patients and established FUSCC as one of China's leading centers for pancreatic oncology, making him a top choice for international patients seeking advanced pancreatic cancer care in Shanghai.
Academic Distinctions & Leadership
- Director, Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center (FUSCC)
- Professor of Surgery, Fudan University Shanghai Medical College
- Chief Physician, Fudan University Shanghai Cancer Center
- Vice Chairman, Pancreatic Disease Branch, Chinese Medical Association
- Chairman, Pancreatic Cancer Committee, Chinese Anti-Cancer Association
- Member, International Association of Pancreatology (IAP)
- Member, Americas Hepato-Pancreato-Biliary Association (AHPBA)
- Editorial Board Member, multiple leading oncology and surgery journals
- Recipient, National Science and Technology Progress Award
- Recipient, Shanghai Science and Technology Award
- Recipient, Wu Jieping Medical Innovation Award
Specializations & Expertise
Pancreatic Cancer Surgery
- Pancreaticoduodenectomy (Whipple procedure) for pancreatic head cancer
- Distal pancreatectomy for pancreatic body and tail cancer
- Total pancreatectomy for diffuse pancreatic cancer
- Radical antegrade modular pancreatosplenectomy (RAMPS)
- Vascular resection and reconstruction for locally advanced disease
- Minimally invasive (laparoscopic and robotic) pancreatectomy
- Re-resection for recurrent pancreatic cancer
Other Pancreatic Tumors
- Intraductal papillary mucinous neoplasm (IPMN)
- Mucinous cystic neoplasm (MCN)
- Solid pseudopapillary neoplasm (SPN)
- Pancreatic neuroendocrine tumors (PNETs)
- Ampullary carcinoma
- Distal cholangiocarcinoma
- Duodenal cancer
Minimally Invasive Pancreatic Surgery
- Laparoscopic distal pancreatectomy
- Robotic-assisted pancreatectomy
- Laparoscopic Whipple procedure
- Minimally invasive enucleation for benign tumors
- Laparoscopic central pancreatectomy
Multidisciplinary Oncology
- Neoadjuvant chemotherapy and chemoradiation for borderline resectable disease
- Conversion surgery after downstaging
- Intraoperative radiation therapy (IORT)
- Palliative surgery and biliary/gastric bypass
- Targeted therapy and immunotherapy integration
Post-operative & Supportive Care
- Enhanced recovery after surgery (ERAS) protocols
- Pancreatic exocrine insufficiency management
- Post-pancreatectomy diabetes management
- Nutritional support and rehabilitation
- Long-term oncologic surveillance
Clinical Excellence & Innovation
Dr. Yu has performed over 3,000 pancreatic surgeries throughout his distinguished career, making him one of the highest-volume pancreatic surgeons in Asia. His R0 resection rates and perioperative outcomes consistently meet or exceed international benchmarks, with 90-day mortality rates well below the national average.
Dr. Yu is a pioneer in pancreatic surgery in China and globally, having introduced several innovative techniques and protocols:
- Artery-First Approach: Developed and standardized artery-first dissection techniques to improve R0 resection rates for pancreatic head cancer
- Radical Antegrade Modular Pancreatosplenectomy (RAMPS): Championed this technique in China to improve oncologic outcomes for left-sided pancreatic cancer
- Vascular Resection Protocols: Pioneered safe portal vein and superior mesenteric vein resection and reconstruction for locally advanced disease
- Minimally Invasive Pancreatectomy: Established one of China's leading robotic and laparoscopic pancreatic surgery programs
- Neoadjuvant Therapy Protocols: Developed multidisciplinary protocols to convert borderline resectable and locally advanced pancreatic cancer to resectable disease
- ERAS Implementation: Introduced enhanced recovery protocols that significantly reduce hospital stay and complications
Under Dr. Yu's leadership, FUSCC's Department of Pancreatic Surgery has become one of China's largest and most innovative, performing over 600 pancreatic surgeries annually with outcomes that rival the best centers globally.
Research & Academic Contributions
Dr. Yu is a prolific researcher with over 400 peer-reviewed publications in leading Chinese and international oncology and surgery journals. His research focuses on:
- Molecular mechanisms of pancreatic cancer progression and metastasis
- Biomarkers for early detection and prognosis of pancreatic cancer
- Novel surgical techniques to improve R0 resection rates
- Neoadjuvant and adjuvant therapy optimization
- Immunotherapy and targeted therapy for pancreatic cancer
- Quality of life after pancreatic surgery
He has been the principal investigator on multiple National Key R&D Programs and National Natural Science Foundation grants. Dr. Yu regularly presents his research at major international conferences including the American Hepato-Pancreato-Biliary Association (AHPBA), the International Association of Pancreatology (IAP), and the European Pancreatic Club (EPC).
His contributions to pancreatic surgery and oncology have been recognized with numerous national and international awards, and he is frequently invited to lecture and perform live surgery demonstrations at conferences worldwide.
Training & Education
As a professor at Fudan University Shanghai Medical College, Dr. Yu is deeply committed to training the next generation of pancreatic surgeons and oncologists. He supervises doctoral and master's degree students and directs one of China's premier pancreatic surgery fellowship programs.
His fellows receive comprehensive training in all aspects of pancreatic surgery, including open, laparoscopic, and robotic techniques, as well as multidisciplinary oncologic management. Many of his trainees now lead pancreatic surgery programs throughout China.
Hospital Affiliation
Fudan University Shanghai Cancer Center (FUSCC)
270 Dongan Road, Xuhui District, Shanghai 200032
FUSCC is China's leading comprehensive cancer center and one of the largest cancer hospitals in Asia. The Department of Pancreatic Surgery features:
- Dedicated pancreatic surgery operating rooms with advanced laparoscopic and robotic equipment
- Specialized surgical oncology ICU
- Comprehensive pre-operative evaluation and staging facilities
- Advanced imaging (MRI, CT, PET-CT, endoscopic ultrasound)
- Multidisciplinary tumor board with weekly pancreatic cancer case conferences
- Multidisciplinary team (surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, gastroenterologists)
- Dedicated pancreatic cancer research laboratory
- Nutritional support and rehabilitation services
- Palliative care and pain management team
- International patient services with English-speaking staff
Patient Care Philosophy
- Patient-Centered Care: Every treatment plan is tailored to the individual patient's tumor biology, overall health, and personal goals
- Multidisciplinary Collaboration: All complex cases are reviewed by a dedicated tumor board of specialists
- Evidence-Based Practice: Treatment decisions guided by the latest international research and guidelines
- Oncologic Radicality: Committed to achieving R0 resection while minimizing morbidity
- Minimally Invasive When Possible: Laparoscopic and robotic approaches used when oncologically appropriate
- Comprehensive Support: Addresses medical, nutritional, psychological, and social needs throughout the cancer journey
- Transparent Communication: Honest, clear communication about diagnosis, prognosis, risks, and treatment options
- Quality of Life Focus: Emphasizes not just survival but optimal quality of life after surgery
Why Choose Dr. Yu Xianjun?
- Unmatched Volume & Experience: Over 3,000 pancreatic surgeries with one of Asia's highest-volume practices
- Exceptional Oncologic Outcomes: High R0 resection rates and survival outcomes that meet international benchmarks
- Comprehensive Capabilities: Expert in all types of pancreatic surgery including complex vascular resections and minimally invasive approaches
- Multidisciplinary Expertise: Leads a world-class tumor board integrating surgery, oncology, and radiation
- Pioneering Research: Actively advances the field through clinical trials and translational research
- High-Volume Center: Over 600 pancreatic surgeries annually at China's top cancer hospital
- Cost-Effective Excellence: Pancreatic cancer surgery costs in Shanghai are typically 60-75% lower than in the US or Europe
- Proven International Track Record: International patients from multiple countries have received successful treatment
Conditions Treated
Malignant Pancreatic Conditions
- Pancreatic ductal adenocarcinoma (PDAC) — resectable, borderline resectable, and locally advanced
- Pancreatic neuroendocrine tumors (PNETs) — functional and non-functional
- Ampullary carcinoma
- Distal cholangiocarcinoma
- Duodenal adenocarcinoma
- Acinar cell carcinoma
- Pancreatic lymphoma
- Metastases to the pancreas (renal cell carcinoma, melanoma, etc.)
Premalignant & Benign Pancreatic Conditions
- Intraductal papillary mucinous neoplasm (IPMN)
- Mucinous cystic neoplasm (MCN)
- Solid pseudopapillary neoplasm (SPN)
- Serous cystadenoma (when symptomatic or large)
- Pancreatic cysts with high-risk features
- Insulinoma and other functional PNETs
- Chronic pancreatitis with pain or complications
International Patient Services
China Medical Concierge - Shanghai (CMCS) provides comprehensive support for international patients seeking pancreatic cancer surgery and treatment with Dr. Yu Xianjun at Fudan University Shanghai Cancer Center.
Pre-Treatment Support
- Medical Record Review: Our team works with FUSCC to review your pathology, imaging, and lab results to assess resectability and treatment options
- Virtual Consultation: Arrange a video consultation with Dr. Yu's team to discuss your case and treatment plan
- Staging Workup Coordination: Comprehensive pre-operative staging including CT, MRI, PET-CT, and endoscopic ultrasound
- Tumor Board Presentation: Your case can be presented at FUSCC's multidisciplinary pancreatic tumor board
- Second Opinion: Expert second opinion on resectability and optimal treatment strategy
- Cost Transparency: Detailed cost estimate including evaluation, surgery, hospitalization, chemotherapy, and follow-up
- Visa Assistance: Guidance on obtaining medical visa and invitation letters
- Accommodation: Help finding suitable housing near FUSCC for patient and family
During Treatment
- Professional Medical Interpretation: Experienced interpreters for all medical interactions
- Hospital Admission Support: Assistance with registration, payment, and navigation
- Family Support: Accommodation and support for accompanying family members
- Surgical Coordination: Communication with family during surgery
- ICU & Ward Support: Daily updates and interpretation during hospital stay
- Post-operative Care: Comprehensive support during recovery including wound care, drain management, and nutrition
- Medication Management: Assistance with post-operative medications and pain management
- 24/7 Emergency Support: Round-the-clock assistance throughout your stay
Post-Treatment Care
- Discharge Planning: Coordination of post-discharge care and monitoring
- Medical Report Translation: Complete translation of surgical reports, pathology, and discharge summaries
- Adjuvant Therapy Coordination: Assistance with arranging adjuvant chemotherapy or radiation if recommended
- Follow-up Coordination: Arrange post-operative clinic visits and imaging surveillance
- Long-term Monitoring Plan: Clear guidance on ongoing surveillance and care schedule
- Complication Management: Support for any post-operative complications
- Telemedicine Follow-up: Virtual consultations for ongoing care after returning home
- Coordination with Home Physicians: Communication with your local oncologist or surgeon
- Lifelong Support: Ongoing assistance throughout your cancer journey
Schedule Your Consultation
If you or a loved one has been diagnosed with pancreatic cancer or a pancreatic tumor, Dr. Yu Xianjun at Fudan University Shanghai Cancer Center offers world-class expertise in pancreatic surgery and oncology with outcomes that rival the best centers globally, at a fraction of Western costs.
Contact China Medical Concierge - Shanghai today to:
- Request a medical record review to assess resectability and treatment options
- Schedule a virtual consultation with Dr. Yu's surgical team
- Have your case presented at FUSCC's multidisciplinary tumor board
- Receive a detailed treatment plan and cost estimate
- Start your journey toward expert pancreatic cancer care in Shanghai
Bridging international patients with China's finest pancreatic surgeons — because every patient deserves access to world-class cancer care.
0 commenti